オプションチェーンは、Springview Holdingsの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Springview Holdingsの市場センチメントを評価します。.

Springview Holdings (NASDAQ:SPHL) 株価情報, オプションチェーン

Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation.

Springview Holdings Ltd - Ordinary shares

Springview Holdings Ltd

WIIM

E.W. Scripps shares are trading higher after the company reported better-than-expected Q4 financial results.

Inflation eased in February, coming in lower than expected and reinforcing the Federal Reserve's path <a href="https://www.benzinga.com/topic/interest-rates">toward interest rate cuts.</a>
The headline Consumer Price Index fell from 3.0% year-over-year in January to 2.8% in February, according to a Bureau of Labor Statistics report released Wednesday. The reading was below economist expectations of 2.9%, as tracked by TradingEconomics, and marked the first decline after four straight months of rising price pressures.
On a monthly basis, CPI increased 0.2% in February, sharply moderating from 0.5% in January and below forecasts of 0.3%.
Core inflation, which excludes food and energy prices, slowed to 3.1% year-over-year, down from 3.3% in January and below forecasts of 3.2%. The monthly increase in core CPI was 0.2%, a cooldown from January's 0.4% pace and below estimates of 0.3%.
The shelter index climbed 0.3% in February, contributing nearly half of the overall monthly CPI increase. This rise was partially counterbalanced by a 4.0% drop in airline fares and a 1.0% decline in gasoline prices. 
Other categories that saw price increases included medical care, used cars and trucks, household furnishings and operations, recreation, apparel, and personal care. Among the few major indexes that declined in February were airline fares and new vehicles.
<h3 class="wp-block-heading">Fed's Outlook: A Step Closer To Rate Cuts</h3>
The softer-than-expected inflation data strengthens the argument for Federal Reserve rate cuts in 2025, as policymakers seek to balance economic risks.
U.S. economic growth is projected to slow sharply in the first quarter, with several investment banks revising GDP forecasts downward. The Atlanta Fed's GDPNow model estimates a potential 2.4% contraction, raising concerns about economic weakness.
With inflation easing and growth concerns mounting, the Fed may find more room to cut rates to support the economy. 
Prior to the report, money markets tracking Fed futures had priced in three to four rate cuts by year-end, according to the CME FedWatch Tool. The latest inflation data could further solidify that outlook.
<h3 class="wp-block-heading">Market Reactions</h3>
<ul>
<li>U.S. dollar: The dollar softened following the inflation report, with the U.S. dollar index, tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>), slipping 0.1% as traders priced in a higher likelihood of rate cuts. </li>
<li>Treasury yields: The 10-year U.S. Treasury yield edged lower by 2 basis points to 4.26%.</li>
<li>Stock market: U.S. equity futures turned higher, with S&amp;P 500 futures up 1.4% in premarket trading at 8:35 a.m. ET. On Tuesday, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) closed at $555.92, its lowest level in seven months and 3% below its 200-day moving average. Contracts on the tech-heavy Nasdaq 100 were 1.6% higher. </li>
</ul>
Read now: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44270128/us-recession-probability-escalates-to-35-amid-tariffs-pimco-sounds-alarm">US Recession Risk Surges To 35%, Pimco Cautions On Economic Fallout From Trump&#8217;s Tariffs</a></li>
</ul>
Photo: Janews/Shutterstock

Macro Economic Events

Econ #s

Economics

Federal Reserve

PowerShares DB US Dollar Index Bullish Fund

Inflation Cools More Than Expected In February, Strengthens The Case For Fed Rate Cuts

MYGN

Myriad Genetics shares are trading higher after Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $11.5 to $12.5.

B of A Securities analyst Tazeen Ahmad maintains Arvinas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>) with a Buy and lowers the price target from $54 to $28.

News

Price Target

Analyst Ratings

ARVN

B of A Securities Maintains Buy on Arvinas, Lowers Price Target to $28

Palantir Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) has been on a wild ride &#8211; up 215.99% over the past year, but down 33.51% in just the last month. The stock is now stuck below its key moving averages, flashing strong bearish signals. 
Can the upcoming AIPCon and a wave of high-profile deals set PLTR up for a turnaround?
<h2 class="wp-block-heading">Is PLTR Stock Facing A Technical Knockout?</h2>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="618" height="487" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/12070947/Screenshot-2025-03-12-at-4.37.59-PM.png" alt="" class="wp-image-820535" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/12070947/Screenshot-2025-03-12-at-4.37.59-PM.png 618w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/12070947/Screenshot-2025-03-12-at-4.37.59-PM-300x236.png 300w" sizes="(max-width: 618px) 100vw, 618px" /></a></figure>
<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
PLTR stock, at $78.05, is trading below its five, 20 and 50-day exponential moving averages, signaling continued selling pressure. The eight-day simple moving average (SMA) at $81.98, 20-day SMA at $94.60 and 50-day SMA at $86.96 all suggest the stock is still in bearish territory.
However, the 200-day SMA at $51.95 paints a different picture, hinting at longer-term strength.
Momentum indicators aren't helping the bulls either. The MACD at a negative 3.95 is firmly bearish, while the RSI at 39.82 signals PLTR stock isn't quite oversold yet.
Read Also: <a href="https://www.benzinga.com/markets/equities/25/03/44267822/palantir-executive-pushes-pentagon-to-adopt-software-first-approach-noting-us-allocates-less-than-1-of-defense-budget-to-modern-battlefield">Palantir Calls For &#8216;Software-First Approach&#8217; As Pentagon Spends Under 1% On Modern Warfare</a>
<h2 class="wp-block-heading">AIPCon &amp; New Deals: Can They Break The Trend?</h2>
Palantir is gearing up for its sixth AIPCon on March 13, where it will <a href="https://investors.palantir.com/news-details/2025/Palantirs-Latest-Wave-of-Customers-Take-Center-Stage-at-AIPCon/">showcase </a>new AI-driven partnerships. 
Big-name customers like Heineken NV (OTCPK:HEINY), Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) and AT&amp;T Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>) are on board, while fresh government contracts, including a $178 million defense <a href="https://in.investing.com/news/company-news/palantir-to-host-aipcon-with-new-customer-reveals-93CH-4716118">deal</a> for mobile battle stations, keep rolling in.
On the tech front, Palantir is strengthening its grip in autonomous drones (<a href="https://in.benzinga.com/news/contracts/25/03/44248119/ondas-taps-palantirs-ai-to-scale-autonomous-systems-stock-jumps">Ondas Holdings partnership</a>) and space security (<a href="https://www.benzinga.com/trading-ideas/long-ideas/25/01/43170228/palantir-takes-aim-at-microsofts-22-billion-army-contract-as-ai-push-expands">Voyager Technologies collaboration</a>). 
But will these be enough to shift sentiment?
<h2 class="wp-block-heading">Long-Term Bulls Vs. Short-Term Bears</h2>
Despite its expanding influence, Palantir's stock is stuck in a bearish trend. AIPCon could provide the narrative boost bulls need, but the technicals suggest caution. 
For now, the stock remains a battleground between long-term believers and short-term skeptics.
Will Palantir stock break free from this slump or is the AI hype cooling off?
Investors will be watching closely.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/03/44227856/nasdaq-sp-500-hit-6-month-lows-as-recession-fears-grow-whats-driving-markets-monday">Nasdaq, S&amp;P 500 Hit 6-Month Lows As Recession Fears Grow: What&#8217;s Driving Markets Monday?</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Technicals

Tech

Trading Ideas

HEINY

PLTR

Palantir's Stock Takes A Hit: Will AIPCon And Defense Deals Be The Comeback Catalyst?

MLYS

Mineralys Therapeutics shares are trading lower after the company announced a $175 million public offering.

On Tuesday, Super Micro Computer, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) introduced a wide range of systems fully optimized for <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/n44262166/supermicro-brings-superior-performance-and-efficiency-to-ai-at-the-edge" rel="noreferrer noopener">edge and embedded workloads</a>.
Several of these new compact servers, based on the latest Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) Xeon 6 SoC processor family (formerly codenamed Granite Rapids-D), empower businesses to optimize real-time AI inferencing and enable smarter applications across many key industries.
CEO Charles Liang noted that as the demand for Edge AI solutions grows, businesses need highly reliable, compact systems that can process data at the edge in real-time.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/03/44258204/asana-called-a-profit-story-but-growth-lag-sparks-jp-morgan-price-forecast-cut" rel="noreferrer noopener">Asana Growth Materially Lags Peers, JP Morgan Cuts Price Forecast</a>
The company&#8217;s latest edge server generation delivers advanced AI capabilities for enhanced efficiency and decision-making and is fully optimized for workloads such as Edge AI, telecom, networking, and CDN, Liang added.
Supermicro&#8217;s new SYS-112D series systems help to run high-performance Edge AI solutions and feature the recently launched Intel Xeon 6 SoC with P-cores. These servers feature increased performance, improved performance per watt, and higher memory bandwidth compared to previous generations of systems.
Supermicro&#8217;s SYS-112D-36C-FN3P features the Intel Xeon 6 SoC. It is ideal for Edge AI and media workloads. Its chassis can easily be deployed in space-constrained environments or embedded in larger systems. Another server based on the same platform, the SYS-112D-42C-FN8P, provides a more telco-optimized configuration.
Supermicro is also introducing two new compact systems, the SYS-E201-14AR and SYS-E300-14AR, which are optimized for IoT and AI inferencing at the far edge. Both systems feature the 15th&nbsp;Gen Intel&nbsp;CoreTM&nbsp;Ultra processors (codenamed Arrow Lake).
The SYS-E300 enables the system to expand its performance for Edge AI applications in security and surveillance, retail, healthcare, manufacturing, and more.
Supermicro&#8217;s edge AI systems in the edge data center can install the recently launched Intel Xeon 6700 and 6500 series processors with P-cores.
Rosenblatt analyst Kevin Cassidy <a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/03/44227833/supermicros-ai-boom-liquid-cooling-edge-spark-analyst-confidence-in-growth-potential" rel="noreferrer noopener">reinstated coverage on</a> Supermicro, citing its liquid cooling at scale and AI-ready systems as major drivers of long-term growth and gross margin upside. Supermicro&#8217;s AI revenues are now nearly 70% of sales and are accelerating, with visibility increasing to 1-2 years.
Price Action:&nbsp;SMCI stock is up 7.20% at $43.78 premarket at last check Wednesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/03/44245077/amd-unleashes-new-ai-focused-chips-to-power-smarter-networks-and-edge-devices" target="_blank" rel="noreferrer noopener">Advanced Micro Devices Unleashes AI-Focused Chips Powered By &#8216;Zen5&#8217; Core Architecture</a></li>
</ul>
Photo by CryptoFX via Shutterstock

Movers

INTC

SMCI

Supermicro Taps Intel Chips To Power Real-Time AI At The Edge, Eyes Growth In IoT And Healthcare

AREC

American Resources Announces Commissioning Of Preparative Scale Sequential Simulated Moving Bed Production Unit

B of A Securities analyst Lorraine Hutchinson maintains Kohl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) with a Underperform and lowers the price target from $15 to $8.

B of A Securities Maintains Underperform on Kohl's, Lowers Price Target to $8

EHang Holdings shares are trading higher. The company reported Q4 financial results.

Needham analyst Mayank Tandon reiterates Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) with a Buy and maintains $220 price target.

Reiteration

GLOB

Needham Reiterates Buy on Globant, Maintains $220 Price Target

As of March 12, 2025, two stocks in the industrials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Astronics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRO#NASDAQ">ATRO</a>)</h3>
<ul>
<li>On March 4, Astronics reported better-than-expected fourth-quarter financial results and issued FY25 revenue guidance with its midpoint above estimates. Peter J. Gundermann, Chairman, President and Chief Executive Officer, commented, &#8220;2024 was another year of solid progress ending with a strong fourth quarter." The company's stock gained around 31% over the past month and has a <a href="https://www.benzinga.com/quote/ATRO">52-week high of $25.54</a>.</li>
<li>RSI Value: 81.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>ATRO Price Action: Shares of Astronics gained 2.3% to close at $24.59 on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">Energy Recovery Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERII#NASDAQ">ERII</a>)</h3>
<ul>
<li>On Feb. 26, Energy Recovery posted better-than-expected quarterly earnings.. The company's stock gained around 11% over the past month and <a href="https://www.benzinga.com/quote/ERII">has a 52-week high</a> of $20.27.</li>
<li>RSI Value: 70.3</li>
<li>ERII Price Action: Shares of Energy Recovery gained 2% to close at $16.54 on Tuesday. </li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44245496/top-3-health-care-stocks-that-may-keep-you-up-at-night-in-q1">Top 3 Health Care Stocks That May Keep You Up At Night In Q1</a></li>
</ul>

Short Ideas

Pre-Market Outlook

Markets

ATRO

ERII

Top 2 Industrials Stocks That May Collapse In March

B of A Securities analyst Vivek Arya maintains Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) with a Underperform and lowers the price target from $100 to $85.

B of A Securities Maintains Underperform on Teradyne, Lowers Price Target to $85

Adobe Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) will release its first-quarter financial results, after the closing bell, on Wednesday, March 12.
Analysts expect the San Jose, California-based company to report quarterly earnings at $4.97 per share, up from $4.48 per share in the year-ago period. Adobe projects quarterly revenue of $5.66 billion, compared to $5.18 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Dec. 11, 2024, Adobe reported fourth-quarter revenue of $5.61 billion, beating the consensus estimate of $5.54 billion.
Adobe shares fell 0.3% to close at $433.66 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/ADBE/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Citigroup analyst Tyler Radke maintained a Neutral rating and cut the price target from $551 to $490 on March 10, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Wells Fargo analyst Michael Turrin maintained an Overweight rating and slashed the price target from $640 to $600 on March 7, 2025. This analyst has an accuracy rate of 61%.</li>
<li>BMO Capital analyst Keith Bachman maintained an Outperform rating and cut the price target from $570 to $515 on Feb. 19, 2025. This analyst has an accuracy rate of 81%.</li>
<li>Deutsche Bank analyst Brad Zelnick downgraded the stock from Buy to Hold and slashed the price target from $600 to $475 on Jan. 8, 2025. This analyst has an accuracy rate of 69%.</li>
<li>UBS analyst Karl Keirstead maintained a Neutral rating and cut the price target from $525 to $475 on Jan. 3, 2025. This analyst has an accuracy rate of 74%.</li>
</ul>
Considering buying ADBE stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="588" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/11123948/image-70-1024x588.png" alt="" class="wp-image-819213" style="width:563px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/11123948/image-70-1024x588.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/11123948/image-70-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/11123948/image-70-768x441.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/11123948/image-70.png 1117w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44245496/top-3-health-care-stocks-that-may-keep-you-up-at-night-in-q1">Top 3 Health Care Stocks That May Keep You Up At Night In Q1</a></li>
</ul>

Earnings

ADBE

Top Wall Street Forecasters Revamp Adobe Price Expectations Ahead Of Q1 Earnings

Initial 20% Acquisition Completed, Creating New Foundation to Deploy Laser Technology Applications
&nbsp;
NUBURU, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURU#NYSE">BURU</a>), a leader in high-power and high-brightness industrial blue laser technology, is proud to announce the successful completion of the first key step in its strategic acquisition plan focused on the defense and security business sector. This pivotal move aligns with the Company's ongoing commitment to cultivate synergies with its existing laser technology expertise and the adoption of cutting-edge, AI-driven solutions and robotic process automation capabilities by virtue of the recent partnership with NexGenAI.
Following the announcement of entering into a commitment letter to acquire a defense and security hub (which includes two target entities: a defense-tech company and a Software as a Service startup focused on operational resilience) in two stages, NUBURU has now completed the acquisition of an initial 20% ownership interest for an aggregate price of $1.5 million in cash and $23.5 million in five-year notes bearing a 10% interest rate. The second stage, which will require approval by NUBURU's stockholders, involves the acquisition of additional ownership interests, resulting in NUBURU holding a controlling interest in the target entities.

BURU

NUBURU Announces 20% Acquisition In Defense-Tech And SaaS Startup For $1.5M Cash, $23.5M Notes

Preliminary Unaudited Full Year 2024 Revenue of $17.5 Million Exceed Guidance of $10 Million by 75%, Representing 285% Annual Growth
Stockholders' Equity Increase of Approximately $22.3 Million Since September 30, 2024
Continues Progress Toward Closing of Acquisition of Act-On Software, Inc.
SEATTLE, March 12, 2025 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=-I7mCEvnP3PXqrIFBIKKCumfNdMOG12sSybyjTWAm1YduNdHlHrRUmQe_DUDR21ZP3RvUywpfMOczYcpEON8JxIFbpzUGoxcLHyEQjeAmTs=">Banzai International, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNZI#NASDAQ">BNZI</a>) ("Banzai" or the "Company"), a leading marketing technology company that provides essential marketing and sales solutions, today provided preliminary unaudited record pro-forma revenue of $17.5 million for the year ended December 31, 2024 and provided a corporate update on its stockholder equity improvement.
Full Year 2024 Revenue Results
Banzai preliminary unaudited revenue is expected to be $17.5 million for the year ended December 31, 2024, on a pro-forma basis including full year revenue for the recently closed acquisitions of Vidello and OpenReel. This is an increase of 285% from the prior year, and exceeds the top end of the Company's previously announced guidance of $10 million for the full year of 2024 by 75%.
Preliminary selected financial information presented in this release are unaudited, subject to financial closing procedures and adjustments, and provided as an approximation on a pro-forma basis in advance of the Company's announcement of its complete financial results for the full year 2024.
Stockholders' Equity Increase
Banzai's equity value as of February 28, 2025, reflects an overall total stockholders' equity increase of $22.3M. The equity value of the total stockholders' deficit was ($22.8) million on September 30, 2024, as per the Company's 10-Q for the period. This increased to approximately ($0.5) million as of February 28, 2025, an improvement of approximately $22.3 million.

Guidance

BNZI

Banzai Preliminary FY24 Revenue $17.5M; Equity Value As Of February 28, 2025, Reflects An Overall Total Stockholders' Equity Increase Of $22.3M

General

CYRX

Cryoport Announces The Launch Of MVE Biological Solutions' 800 C Cryogenic Freezer Series

U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Wednesday.
Shares of Hello Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOMO#NASDAQ">MOMO</a>) fell sharply during pre-market trading after reporting weak quarterly results.
Hello Group posted fourth-quarter adjusted EPADS of 18 cents missing estimates of 21 cents per shares. The company's sales came in at $361.20 million missing expectations of $365.05 million.
Hello Group shares dipped 12.4% to $6.50 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Lazard, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) dipped 13% to $40.00 in pre-market trading after the company reported February assets under management.</li>
<li>loanDepot, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDI#NYSE">LDI</a>) shares fell 10.4% to $1.44 in pre-market trading after the company reported worse-than-expected fourth-quarter revenue results and a year-over-year decrease in adjusted EPS results.</li>
<li>Amylyx Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMLX#NASDAQ">AMLX</a>) fell 9.9% to $3.36 in today's pre-market trading after gaining 7% on Tuesday.</li>
<li>Mineralys Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLYS#NASDAQ">MLYS</a>) fell 8.3% to $13.10 in pre-market trading. Mineralys Therapeutics priced its $175 million public offering of 12,962,962 common shares at $13.50/share.</li>
<li>MaxCyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MXCT#NASDAQ">MXCT</a>) slipped 7.2% to $3.22 in pre-market trading following quarterly earnings.</li>
<li>XPeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) fell 6.2% to $24.72 in pre-market trading. XPeng shares jumped around 15% on Tuesday after the company announced to spend up to $13.8 billion on humanoid robots.</li>
<li>Owens &amp; Minor, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMI#NYSE">OMI</a>) shares dipped 3.1% to $9.25 in pre-market trading. Owens &amp; Minor recently reported better-than-expected quarterly financial results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44245496/top-3-health-care-stocks-that-may-keep-you-up-at-night-in-q1">Top 3 Health Care Stocks That May Keep You Up At Night In Q1</a></li>
</ul>

Amplify YieldShares Oil Hedged MLP Income ETF

Comments

Springview Holdings

Springview Holdings (SPHL) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル